Skip to main content
. 2023 Mar 31;39(2):97–106. doi: 10.4103/iju.iju_160_22

Table 1.

Characteristics of individual studies

Article reference Age range Number of patients Mean duration of symptoms (months) Mean IPSS Pre-UDS treatment Type of UDS Post-UDS diagnosis Post-UDS management Follow-up

PBNO DV DU DO
Crisp et al., 1976[6] 28-44 8 NA NA NA Conventional 1 0 0 0 NA NA
Abrams et al., 1981[7] 20-45 204 NA NA NA Conventional 21 0 31 12 NA NA
Kaplan et al., 1996[8] 21-50 137 37.6 17.6 Antibiotics-137 (100%), alpha blockers-98 (72%) Video 74 33 7 0 NA NA
Kaplan et al., 1997[9] 23-50 43 33.6 17.5 Antibiotics-43 (100%) Video 30 0 0 17 Behavioural therapy and feedback 3 months
Nitti et al., 2002[3] 18-45 85 NA 19.3 NA Video 40 12 1 5 NA NA
Wang et al., 2003[10] 18-50 90 28.3 19.8 NA Video 37 39 0 0 Multiple NA
Toh and Ng, 2006[11] 17-49 56 NA NA NA Conventional 14 1 5 9 NA NA
Karami et al., 2011[12] 18-40 456 12.3 NA Multiple Conventional 96 69 59 62 NA NA
Jamzadeh et al., 2014[13] 19-40 87 NA NA NA Video 37 25 10 7 NA NA
Jeong et al., 2014[14] 18-50 308 38.8 NA NA Conventional 80 72 39 41 NA NA

NA=Not available, PBNO=Primary bladder neck obstruction, DV=Dysfunctional voiding, DU=Detrusor underactivity, DO=Detrusor overactivity, IPSS=International prostate symptom score, UDS=Urodynamics